Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

245.50p
   
  • Change Today:
      17.00p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 323,416
  • Market Cap: £245.50m
  • RiskGrade: 125

Oxford Biomedica signs licence, supply deal with Cabaletta Bio

By Frank Prenesti

Date: Wednesday 05 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Gene and cell therapy group Oxford Biomedica on Wednesday said it had signed a new license and supply agreement on its LentiVector platform with US-based Cabaletta Bio.
The deal gives Cabaletta a non-exclusive licence for LentiVector to be used on Chimeric autoantibody receptor T programme, DSG3-CAART, for autoimmune disease.

No financial details were revealed, but Oxford Biomendica said the arrangements of the LSA were "in line with comparable deals the group has previously secured".





Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 245.50p
Change Today 17.00p
% Change 7.44 %
52 Week High 470.00
52 Week Low 166.80
Volume 323,416
Shares Issued 100.00m
Market Cap £245.50m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average
84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average
Price Trend
50.63% below the market average50.63% below the market average50.63% below the market average50.63% below the market average50.63% below the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Income Not Available
Growth
6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
14:00 629 @ 247.50p
14:00 10 @ 245.50p
14:00 8 @ 245.50p
14:00 185 @ 245.50p
13:55 804 @ 247.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page